Press Releases
Provepharm announces impressive trading and financial results for 2011
Provepharm, which is specialized in the development of pharmaceutical applications, announces today very healthy trading and financial results for 2011. The company broke even for the first time last year, when its revenues amounted to EUR three million. ...
Press Releases
DNA Electronics CEO Professor Chris Toumazou To Address Scripps “Future of Genomic Medicine” Conference
DNA Electronics Ltd. a developer of semiconductor solutions for real-time DNA and RNA detection, today announces that DNA Electronics Chairman and CEO Professor Chris Toumazou FRS will be an invited speaker at the upcoming “The Future of Genomic Medicine...
Press Releases
Ferrer announces best-in-class results in phase I for Lorediplon in insomnia
Ferrer, a privately-held Spanish pharmaceutical company with full vertical integration from R&D to distribution, today announces that it has completed phase I clinical trials of Lorediplon in insomnia. The trials demonstrated the orally available compound has a best-in-class...
Press Releases
Pharmaceutical regulatory affairs specialist ELC Group establishes global HQ in Cambridge, UK
Cambridge, UK, February 8 2012 – ELC GROUP, the pan-European pharmaceutical regulatory affairs organisation, today formally announces that it has established its global headquarters in Cambridge, UK. The opening of the new global HQ follows a year of...
Press Releases
RBCC Negotiates Funding Terms With n3D
Rainbow Biosciences, the biotech division of Rainbow Coral Corp. announced today that it’s on the cusp of a major breakthrough in its business relationship with n3D Biosciences. Last week, management from RBCC and n3D convened to...
Press Releases
Keller Rohrback L.L.P. Announces Investigation of Pfizer, Inc. Regarding the Lo/Ovral®-28 and Norgestrel Birth Control Pill Recall
Attorney Advertising. Keller Rohrback L.L.P. (www.krcomplexlit.com) is investigating possible consumer claims against Pfizer, Inc. relating to its recent recall of certain lots of Lo/Ovral®-28 and Norgestrel birth control pills that were sold in the U.S. ...
Press Releases
Histogenics Corporation to Present at Canaccord Genuity Musculoskeletal Conference
Histogenics Corporation, a privately held, regenerative medicine company, today announced that President and Chief Executive Officer Patrick O’Donnell will present at the upcoming Canaccord Genuity Musculoskeletal Conference on February 7th at 3:30pm PT at the Parc 55 Wyndham in...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read